The Zimbabwe Event


Covid funeral in Harare

Over the past two weeks, three senior Cabinet officials in Zimbabwe (including the Foreign Minister and the Infrastructure Minister) have died from Covid. Not gotten sick. Died. More broadly, reported Covid cases and deaths have exploded in this country of 15 million just in the month of January. The unreported numbers are certainly much higher, as about 90% of Zimbabwe’s population works outside of the formal economy, and the majority of Zimbabweans have little to no access to the healthcare facilities that report these official case and death numbers.

through Jan. 21 (source:
through Jan. 21 (source:

The societal unraveling that is taking place in Zimbabwe – a desperately poor country where per capita GDP is less than $1,500 and declining – is staggering.

Two days ago, the government’s Information Minister tweeted that his fellow Cabinet members had been “eliminated” and called the nation’s doctors “medical assassins”. He deleted the tweets yesterday and apologized “if anyone was offended”. Nurses at a major hospital in the capital city of Harare are on strike because they are provided a single cloth mask and bakery aprons as PPE. The Defense Minister has accused China of “botched experiments” that brought Covid to Zimbabwe, and has said that she will only accept a vaccine if it is manufactured locally. Today, the government announced that it “plans to buy” cheapo Chinese and Russian vaccines, but can only afford to cover two-thirds of the country’s population. The Harare elite have taken to hoarding – not food, but oxygen– to the point where hospitals are placing newspaper ads promising to pay top dollar for any remaining supply.

This is the ‘Zimbabwe Event’, and I believe it has significant real-world and market-world consequences.

Like the ‘Ireland Event’ I’ve been writing about recently, what is happening in Zimbabwe (and every country in Southern Africa) is driven by a combination of relaxed social mitigation policies AND the introduction of a more infectious SARS-CoV-2 virus variant.

What is different is that Zimbabwe is a “weak state”, not a strong, stable state like Ireland.

What is different is that Zimbabwe is being hit by the South African-variant (501.V2), not the UK-variant virus (B117). 

The “Weak State” Difference

The stress of the Covid pandemic is enormous in ALL countries, and it is stress at EVERY stratum of society. The poor are dying. The middle class is dying and getting poorer. The elite are not dying quite as much, but they’re not getting richer and the difference in outcomes between some elites and other elites is enormous.

This broad societal stress results in popular discontent and elite conflict in every country on Earth.

Rich country or poor country, weak state or strong state, big nation or small nation … doesn’t matter. ALL nations are experiencing much higher levels of popular discontent and elite conflict today, which means that ALL governments are experiencing much higher pressure for regime change and leadership transitions.

In a strong state – meaning a nation that has the institutions, traditions, narrative legitimacy and state-supporting common knowledge to accommodate a peaceful leadership transition even under times of intense stress – you can survive a Covid Event without violent regime change.

In a weak state – meaning a nation that does NOT have the institutions, traditions, narrative legitimacy and state-supporting common knowledge to accommodate a peaceful leadership transition under times of intense stress – you cannot.

Weak states do not have an effective political steam valve for popular discontent and elite conflict, resulting in war and violent regime change when a Covid Event hits.

The United States is a strong state. It is, arguably, the strongest state in the world, with an institutional legitimacy and broad-based popular loyalty to those core institutions that has few peers. The United States has many political steam valves for the expression of popular discontent and elite conflict.

If the events of January 6th and the storming of the Capitol can happen in the United States, can you imagine what’s possible in Harare? In Tehran? In Moscow?

In a desperately poor country like Zimbabwe – and there are a lot of Zimbabwes in the world – the violence of popular discontent and elite conflict is obvious enough. When the core functions of a domestic government effectively collapse, civilian life in these circumstances quickly becomes, as Hobbes would say, nasty, brutish and short. The outcome of these circumstances is ALWAYS war. First a war of all against all, then a war of organized factions, then (often) a war of nations. Some of these wars in the Zimbabwes of the world will be entirely internal to existing borders. Some of these wars will cross those borders. Some of these wars will include major powers. 

I think 2021 will be a Year of Civil War in weak states that are desperately poor.

The market couldn’t care less about that, of course, whatever the human enormity of this violence might be.

But the dynamics I’m describing are not only true for an insanely poor weak state like Zimbabwe, but are also true for a relatively wealthy weak state like South Africa. Or Iran. Or Russia.

If you don’t see that the Navalny protests and the growing popular discontent with Putin and his billion dollar palace and all that is both made possible and accelerated by the enormous stress that Covid has placed on the Russian economy and public health … well, I think you’re missing the larger picture here. By the same token, I also think it’s clear that there is real and significant elite conflict behind the protests you see on TV, similarly stemming from that stress on the Russian economy. Clausewitz famously said that war is the continuation of politics by other means. In weak states, though, the reverse is also true: politics is the continuation of war by other means. Right now, Russia is a political war of all against all. Can Putin survive this political war? Sure. But if he does, it won’t be pretty. My bet is that he “retires for health reasons”.

I could absolutely see the same thing happening with Khamenei in Iran. Or MBS in Saudi Arabia.

I think 2021 will be a Year of Unexpected Regime Change in weak states that are relatively wealthy.

The market will care about this a great deal.

The S. African-Variant (501.V2) Difference

My notes about the Ireland Event focused on two questions:

1) how likely is a rolling series of B117-driven Ireland Events in the United States? (very, in my opinion)

2) where are we in the timeline for the first of these US-based Ireland Events? (2 to 3 weeks from today, in my opinion)

There was a third question embedded in all this, of course, which is what the market response might be to an Ireland Event here in the United States. Again imo, I don’t see this as a similar risk as last March. I really don’t see this as an epic major market smackdown, provided that the Fed and the White House say all the right things about unlimited liquidity support for S&P 500 companies … which they will. But I DO see this as a sharp punch in the nose to all of the dominant investment themes and narratives today: “dollar debasement”, “reflation”, “number go up” (Bitcoin), “commodity supercycle”, “cyclical recovery”, “earnings recovery”, “pent-up consumer spending”, etc. etc.

Is it just one good punch to all risk assets before we return to our regularly scheduled market entertainment of looking through previously unthinkable numbers of deaths and cases to some happy day of fully vaccinated business as usual?

Probably. But more and more I’m thinking it’s a very solid punch. More and more I’m thinking that this is a tradable punch. I say this for four reasons:

1) There is a sharp difference in general media coverage of the risk of viral variant spread versus financial media coverage of the risk of viral variant spread. 

While there’s an almost willful ignoring of the virus variants in major financial media, this is not the case with major non-financial media, where coverage of the news and risks of viral variant spread shows both “coherence” and “strength”, to use our narrative structure terms. Notably, however, even in non-financial media, the sentiment associated with articles about viral variant spread is oddly … positive. Like it’s really not a big deal and with Team Biden at the helm we got this covered! Yay, Team Biden! I think this is a classic example of narrative complacency, particularly in financial media, where all of the narrative risks right now are to the downside.

2) There are now four independent medical studies showing that the B117 variant is both more infectious AND more lethal than the baseline virus, versus zero medical studies showing only the same lethality (you can download a PDF copy of the most recent NERVTAG paper here). 

While the mathematical truth is that increased lethality is not nearly as “dangerous” from a public health perspective as increased infectiousness, from a popular perspective just the reverse is true. Stories of increased lethality carry a lot more narrative punch than stories of increased infectiousness. When there’s a confirmation of the lethality data (and I think it’s a when, not an if), that’s a hard hit to the “variants aren’t a big deal” narrative.

3) We now have multiple examples of a B117-driven Ireland Event, not just in Ireland and the UK, but also now in Portugal, Spain and Israel, and coming soon to the rest of continental Europe. 

The ‘Israel Event’ is particularly chastening, as the explosion in Covid cases occurred despite the most advanced vaccination program in the world, with close to 40% of the population vaccinated even as the Event occurred. As I wrote last week, one of the major consequences of a more infectious viral strain is that the percentage of the population that must be vaccinated before herd immunity brings down the R-number is significantly higher than with a less infectious viral strain, so that even 40% is only a modest help in limiting new infections. Also, and this is even more problematic news, Israel reports that a single dose of the vaccines that originally contemplated a two-dose regimen is notably less effective than was suggested in clinical trials. Whether this reduced efficacy for one dose of a two-dose vaccine is because of something particular to the B117 variant is unknown. Either way, that gets us to the last and more important point.

4) The potential for reduced vaccine efficacy is at the heart of why I think the 501.V2 variant is so important, both in real-world and in market-world. 

On Monday, we got the first hard evidence on vaccine efficacy versus 501.V2 (you can read the full Moderna press release here), largely duplicating the findings of South African studies earlier this month of antibody protection from prior baseline Covid infections. These are in vitro tests (lab tests) on the sera (blood) of vaccinated (Moderna analysis) or previously Covid-infected (S. African analysis) patients to measure how much “neutralizing” the antibodies in this vaccinated or previously Covid-infected sera gives you against the new virus variant. There will always be some degradation in neutralizing efficacy, but it’s a matter of degree as for whether you can keep going with the existing vaccine or whether you need a booster shot or whether you need to develop a new vaccine or what. The results from both studies, showing a “six-fold reduction in neutralizing titers” (vaccine protection) and an “eight-fold reduction in neutralizing titers” (prior Covid-infection protection) are on the okay side of “meh” but are still pretty “meh”. These are “yes, but” results.

YES, the current Moderna vaccine appears to be technically effective against 501.V2, meaning that it should provide a greater than 50% chance of protection against serious illness from contracting Covid. My interpretation of a “six-fold reduction in neutralizing titers” is that it’s roughly as effective as last year’s flu vaccine would be for this year’s flu (happy to be corrected on this by anyone who knows better). That’s not nothing! It’s a lot, in fact. BUT it’s a far cry from the efficacy we’ve seen in clinical trials against the non-variant virus, which is really outstanding.

In market-world, I think it is impossible to overstate the destabilizing impact of a Covid variant that is vaccine-resistant.

And to be clear, 501.V2 is probably not that variant. If it were, then I’d be worried about a lot more than just a transitory punch to the market’s nose. Also to be clear, I don’t think 501.V2 in the United States is even in the case, case, case phase of the nothing, nothing, nothing … case, case, case … cluster, cluster, cluster … BOOM! cycle of exponential virus spread. B117 is the immediate threat here, not 501.V2.

But what we DO have with 501.V2 is the start of a vaccine-resistant Covid variant narrative.

I hope that’s all it ever is … the start of a vaccine-resistance story that never develops into a vaccine-resistance reality! But for market-world, the mere existence of a narrative like this, even in an embryonic state, is enough to drive tradeable market events.

Put this together with recent developments with B117 … put the imminent impact of a US-based Ireland Event together with the long-term and geopolitical impact of Zimbabwe Events … and yeah, I think you’ve got a tradeable punch coming to markets.


To learn more about Epsilon Theory and be notified when we release new content sign up here. You’ll receive an email every week and your information will never be shared with anyone else.

Notify of
Inline Feedbacks
View all comments
Travis Clarke
1 month ago

This note hit me different today because I just read a post by Radigan Carter called The Wall Street Insurgency and so regime change is top of mind. I love the way you describe exponential growth of the virus as “nothing, nothing, nothing … case, case, case … cluster, cluster, cluster … BOOM!” The reason I love that description of exponential growth is because it can describe how ideas, narratives, movements, etc. all grow too. In Radigan’s note he describes how it felt in countries that you describe above as “weak states” when they start to fracture. And I think the reason your post really has me troubled is that I don’t think the US has functioning “political steam valves for the popular discontent and elite conflict” right now as you say above. Whether it is r/WallStreetBets or the storming of the Capitol or the protests and riots over the summer or Bitcoin or any other of these expressions of popular discontent, I feel like these are the real time data points in the “case, case, case … cluster, cluster, cluster” phase of a movement to reopen our political steam valves. I worry because they don’t seem to be budging and the pressure is building. I wonder if we are too far down a growth path that leads to “weak state” events happening to let off that steam. I believe the US is still a “strong state” but in a weakened position and not sure what type of shape we are… Read more »

Brian Scaletta
1 month ago
Reply to  Travis Clarke

I read the same things this morning and agree the US is in a vulnerable strong state position. My confusion around Covid is how many shots per person are we really talking about? If I were to get 2 shots today for original Covid, then I need 1 booster shot this summer for the new variant and then again 1 booster shot in the fall for the new, new variant? Thanks to the pack for any thoughts or readings on this.

1 month ago

Market is positioned as if no one believes a variant is a serious threat, or maybe everyone is just too obsessed with GME to be paying attention. Short interest is going to be next to nothing after all the covering from Game Stop debacle. Commodities are ripping higher with Powell reiterating green light and ABC news just tweeted, “in the span of 2 weeks, the national 7 day average of daily cases has declined by 34% – the steepest nonholiday drop. The US has seen since the summer.” Everybody is getting ready to take off their mask.

And just anecdotal, Fort Bend ISD (7th largest school district in Texas), has closed 12 schools this week because of rapid spread. 12 schools is not a lot, guessing 8000 students since there’s 3000 at one high school, but they didn’t do this in the fall, is something new. No idea if it’s the new variant or not, but they are taking it seriously.

1 month ago

interesting theory. So we should expect to see a new surge in cases (with deaths on a lag) starting in 2-3 weeks. If not, we dodged a bullet, or it just wasn’t as lethal in the US.

Simons Chase
1 month ago

Five trillion units of centrally-planned fear sterilization should fix this. And I thought viral variant spread was a yoga position.

1 month ago

NVAX trial results on UK and South Africa variants were fairly encouraging, although not as positive for South African variant. It still feels like a red or black from a trading perspective where we have no edge for position. Here’s a link to the PDF, conference call is mostly just patting each other on the back, but there are a few nuggets in there. They are in discussion with US FDA for EUA, but it would be 2 to 3 months before formal data is released. That statement seems crazy considering how fast other approvals have been.

1 month ago

I’m curious on this variation playing out. We’re targeting the elderly as one of the first recipients of most vaccines. This population tends to have weaker response to vaccines in general (hence the “high dose” flu vaccine) and lower immune response in general. We also have a virus which has a degree of immune escape already (re-infection, likely happening in Manaus, Brazil), in addition to transmissibility which causes it to become the dominant strain over base COVID within 2-3 months of introduction.

There is going to be a high degree of contact between vaccinated individuals with limited immune response and this variant that has some immune escape. This seems like it’s the preferred evolutionary ramp to total immune escape – a large number of training grounds against the vaccine at full effectiveness in a younger population. How long until we have a “Florida” variant which carries on the SA or BR efforts and does provide for reinfection?

And if this occurs, does that feed into a narrative of “the vaccine was 5g mind control all along!”

A minor sidenote on this – the UK variant seems to disprove the misused theory that evolution selects for less lethality (no, evolution selects for transmissibility and growth and doesn’t care about lethality so long as it doesn’t hinder the above). No evidence that as it becomes better adapted to humans, that we don’t see at least some further lethality increases.

Lawrence Pusateri
1 month ago

“The United States is a strong state. It is, arguably, the strongest state in the world, with an institutional legitimacy and broad-based popular loyalty to those core institutions”

This line has been ringing around in my head for a few days.

I certainly wont argue that the institutional legitimacy has relative broad based support.

If , however, that is a major factor – we sure are a MUCH weaker state than we were a decade ago. I need to re-read first the people.

The Long Now indeed.

James Wire
1 month ago

Ben, “nothing, nothing, nothing … case, case, case … cluster, cluster, cluster … BOOM!” captures exponential spread so well. I don’t recall anything for narratives, maybe in an older note?

The Latest From Epsilon Theory


This commentary is being provided to you as general information only and should not be taken as investment advice. The opinions expressed in these materials represent the personal views of the author(s). It is not investment research or a research recommendation, as it does not constitute substantive research or analysis. Any action that you take as a result of information contained in this document is ultimately your responsibility. Epsilon Theory will not accept liability for any loss or damage, including without limitation to any loss of profit, which may arise directly or indirectly from use of or reliance on such information. Consult your investment advisor before making any investment decisions. It must be noted, that no one can accurately predict the future of the market with certainty or guarantee future investment performance. Past performance is not a guarantee of future results.

Statements in this communication are forward-looking statements. The forward-looking statements and other views expressed herein are as of the date of this publication. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements, and there is no guarantee that any predictions will come to pass. The views expressed herein are subject to change at any time, due to numerous market and other factors. Epsilon Theory disclaims any obligation to update publicly or revise any forward-looking statements or views expressed herein. This information is neither an offer to sell nor a solicitation of any offer to buy any securities. This commentary has been prepared without regard to the individual financial circumstances and objectives of persons who receive it. Epsilon Theory recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial advisor. The appropriateness of a particular investment or strategy will depend on an investor’s individual circumstances and objectives.